AI assistant
AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2015
Feb 17, 2015
31580_dirs_2015-02-17_ee330ed0-f08c-4ca2-8b0b-d6173e38ced1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2015-02-13
Reporting Person: Goddard Glenn (Senior Vice President, Finance)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-02-13 | Common stock | M | 1316 | $23.10 | Acquired | 1316 | Direct |
| 2015-02-13 | Common stock | S | 1316 | $120.31 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-02-13 | Stock option (right to buy) | $23.10 | M | 1316 | Disposed | 2023-08-27 | Common stock (1316) | Direct |
Footnotes
F1: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F3: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $120.00 to $121.08. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price
F4: This option was granted on August 28, 2013. The shares underlying this option vest as to 25% of the underlying shares on August 28, 2014, with the remaining 75% vesting in 36 equal monthly installments thereafter.